aluates Reports

$ 0.0

Automative

Global Human Immunodeficiency Virus Type-1 Market Research Report 2026

Published Date: 2026-03-12

Report Code: QYRE-Auto-36S17850

Global Human Immunodeficiency Virus Type 1 Market Research Report 2024

BUY CHAPTERS

Global Human Immunodeficiency Virus Type-1 Market Research Report 2026

Code: QYRE-Auto-36S17850

Report

2026-03-12

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Bristol–Myers Squibb

Merck& Co. Inc

Viatris

Astrazeneca plc

Novartis

Bayer

Merck& Co. Inc

Human Immunodeficiency Virus Type-1 Market

The global Human Immunodeficiency Virus Type-1 market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The North American market for Human Immunodeficiency Virus Type-1 is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Human Immunodeficiency Virus Type-1 is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Human Immunodeficiency Virus Type-1 in Hospital Pharmacies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Human Immunodeficiency Virus Type-1 include Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, Viatris, Sanofi, AstraZeneca, Novartis, Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Human Immunodeficiency Virus Type-1 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Immunodeficiency Virus Type-1. The Human Immunodeficiency Virus Type-1 market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Human Immunodeficiency Virus Type-1 market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Human Immunodeficiency Virus Type-1 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Human Immunodeficiency Virus Type-1 Market Report

Report Metric	Details
Report Name	Human Immunodeficiency Virus Type-1 Market
Segment by Type	Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Protease Inhibitors (PIs) Integrase Inhibitor Others
Segment by Application	Hospital Pharmacies Retail Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, Viatris, Sanofi, AstraZeneca, Novartis, Bayer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Human Immunodeficiency Virus Type-1 companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Human Immunodeficiency Virus Type-1 Market report?

Ans: The main players in the Human Immunodeficiency Virus Type-1 Market are Roche, Bristol Myers Squibb, Merck & Co. Inc., GSK, Pfizer, Viatris, Sanofi, AstraZeneca, Novartis, Bayer

What are the Application segmentation covered in the Human Immunodeficiency Virus Type-1 Market report?

Ans: The Applications covered in the Human Immunodeficiency Virus Type-1 Market report are Hospital Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Human Immunodeficiency Virus Type-1 Market report?

Ans: The Types covered in the Human Immunodeficiency Virus Type-1 Market report are Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs), Protease Inhibitors (PIs), Integrase Inhibitor, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

1.2.3 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)

1.2.4 Protease Inhibitors (PIs)

1.2.5 Integrase Inhibitor

1.2.6 Others

1.3 Market by Application

1.3.1 Global Human Immunodeficiency Virus Type-1 Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Immunodeficiency Virus Type-1 Market Perspective (2021–2032)

2.2 Global Human Immunodeficiency Virus Type-1 Growth Trends by Region

2.2.1 Global Human Immunodeficiency Virus Type-1 Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Human Immunodeficiency Virus Type-1 Historic Market Size by Region (2021–2026)

2.2.3 Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (2027–2032)

2.3 Human Immunodeficiency Virus Type-1 Market Dynamics

2.3.1 Human Immunodeficiency Virus Type-1 Industry Trends

2.3.2 Human Immunodeficiency Virus Type-1 Market Drivers

2.3.3 Human Immunodeficiency Virus Type-1 Market Challenges

2.3.4 Human Immunodeficiency Virus Type-1 Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue

3.1.1 Global Top Human Immunodeficiency Virus Type-1 Players by Revenue (2021–2026)

3.1.2 Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Players (2021–2026)

3.2 Global Top Human Immunodeficiency Virus Type-1 Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Human Immunodeficiency Virus Type-1 Revenue

3.4 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio

3.4.1 Global Human Immunodeficiency Virus Type-1 Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus Type-1 Revenue in 2025

3.5 Global Key Players of Human Immunodeficiency Virus Type-1 Head Offices and Areas Served

3.6 Global Key Players of Human Immunodeficiency Virus Type-1, Products and Applications

3.7 Global Key Players of Human Immunodeficiency Virus Type-1, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Human Immunodeficiency Virus Type-1 Breakdown Data by Type

4.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Type (2021–2026)

4.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (2027–2032)

5 Human Immunodeficiency Virus Type-1 Breakdown Data by Application

5.1 Global Human Immunodeficiency Virus Type-1 Historic Market Size by Application (2021–2026)

5.2 Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Human Immunodeficiency Virus Type-1 Market Size (2021–2032)

6.2 North America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)

6.4 North America Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Immunodeficiency Virus Type-1 Market Size (2021–2032)

7.2 Europe Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)

7.4 Europe Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size (2021–2032)

8.2 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2021–2026)

8.4 Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Human Immunodeficiency Virus Type-1 Market Size (2021–2032)

9.2 Latin America Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)

9.4 Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size (2021–2032)

10.2 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2021–2026)

10.4 Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Human Immunodeficiency Virus Type-1 Introduction

11.1.4 Roche Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Bristol Myers Squibb

11.2.1 Bristol Myers Squibb Company Details

11.2.2 Bristol Myers Squibb Business Overview

11.2.3 Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Introduction

11.2.4 Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.2.5 Bristol Myers Squibb Recent Development

11.3 Merck & Co. Inc.

11.3.1 Merck & Co. Inc. Company Details

11.3.2 Merck & Co. Inc. Business Overview

11.3.3 Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Introduction

11.3.4 Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.3.5 Merck & Co. Inc. Recent Development

11.4 GSK

11.4.1 GSK Company Details

11.4.2 GSK Business Overview

11.4.3 GSK Human Immunodeficiency Virus Type-1 Introduction

11.4.4 GSK Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.4.5 GSK Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Human Immunodeficiency Virus Type-1 Introduction

11.5.4 Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.5.5 Pfizer Recent Development

11.6 Viatris

11.6.1 Viatris Company Details

11.6.2 Viatris Business Overview

11.6.3 Viatris Human Immunodeficiency Virus Type-1 Introduction

11.6.4 Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.6.5 Viatris Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Human Immunodeficiency Virus Type-1 Introduction

11.7.4 Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.7.5 Sanofi Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Human Immunodeficiency Virus Type-1 Introduction

11.8.4 AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.8.5 AstraZeneca Recent Development

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Human Immunodeficiency Virus Type-1 Introduction

11.9.4 Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.9.5 Novartis Recent Development

11.10 Bayer

11.10.1 Bayer Company Details

11.10.2 Bayer Business Overview

11.10.3 Bayer Human Immunodeficiency Virus Type-1 Introduction

11.10.4 Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (2021–2026)

11.10.5 Bayer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Bristol–Myers Squibb

Merck& Co. Inc

Viatris

Astrazeneca plc

Novartis

Bayer

Merck& Co. Inc

List of Tables

Table 1. Global Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Table 3. Key Players of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)

Table 4. Key Players of Protease Inhibitors (PIs)

Table 5. Key Players of Integrase Inhibitor

Table 6. Key Players of Others

Table 7. Global Human Immunodeficiency Virus Type-1 Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2021–2026

Table 10. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2021–2026)

Table 11. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Human Immunodeficiency Virus Type-1 Market Share by Region (2027–2032)

Table 13. Human Immunodeficiency Virus Type-1 Market Trends

Table 14. Human Immunodeficiency Virus Type-1 Market Drivers

Table 15. Human Immunodeficiency Virus Type-1 Market Challenges

Table 16. Human Immunodeficiency Virus Type-1 Market Restraints

Table 17. Global Human Immunodeficiency Virus Type-1 Revenue by Players (US$ Million), 2021–2026

Table 18. Global Human Immunodeficiency Virus Type-1 Market Share by Players (2021–2026)

Table 19. Global Top Human Immunodeficiency Virus Type-1 Players by Tier (Tier 1, Tier 2, and Tier 3), based on Human Immunodeficiency Virus Type-1 Revenue, 2025

Table 20. Ranking of Global Top Human Immunodeficiency Virus Type-1 Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Human Immunodeficiency Virus Type-1 Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Human Immunodeficiency Virus Type-1, Headquarters and Area Served

Table 23. Global Key Players of Human Immunodeficiency Virus Type-1, Products and Applications

Table 24. Global Key Players of Human Immunodeficiency Virus Type-1, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Human Immunodeficiency Virus Type-1 Market Size by Type (US$ Million), 2021–2026

Table 27. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2021–2026)

Table 28. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Type (2027–2032)

Table 30. Global Human Immunodeficiency Virus Type-1 Market Size by Application (US$ Million), 2021–2026

Table 31. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2021–2026)

Table 32. Global Human Immunodeficiency Virus Type-1 Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Human Immunodeficiency Virus Type-1 Revenue Market Share by Application (2027–2032)

Table 34. North America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026

Table 36. North America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size by Country (US$ Million), 2027–2032

Table 49. Roche Company Details

Table 50. Roche Business Overview

Table 51. Roche Human Immunodeficiency Virus Type-1 Product

Table 52. Roche Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 53. Roche Recent Development

Table 54. Bristol Myers Squibb Company Details

Table 55. Bristol Myers Squibb Business Overview

Table 56. Bristol Myers Squibb Human Immunodeficiency Virus Type-1 Product

Table 57. Bristol Myers Squibb Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 58. Bristol Myers Squibb Recent Development

Table 59. Merck & Co. Inc. Company Details

Table 60. Merck & Co. Inc. Business Overview

Table 61. Merck & Co. Inc. Human Immunodeficiency Virus Type-1 Product

Table 62. Merck & Co. Inc. Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 63. Merck & Co. Inc. Recent Development

Table 64. GSK Company Details

Table 65. GSK Business Overview

Table 66. GSK Human Immunodeficiency Virus Type-1 Product

Table 67. GSK Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 68. GSK Recent Development

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Human Immunodeficiency Virus Type-1 Product

Table 72. Pfizer Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 73. Pfizer Recent Development

Table 74. Viatris Company Details

Table 75. Viatris Business Overview

Table 76. Viatris Human Immunodeficiency Virus Type-1 Product

Table 77. Viatris Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 78. Viatris Recent Development

Table 79. Sanofi Company Details

Table 80. Sanofi Business Overview

Table 81. Sanofi Human Immunodeficiency Virus Type-1 Product

Table 82. Sanofi Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 83. Sanofi Recent Development

Table 84. AstraZeneca Company Details

Table 85. AstraZeneca Business Overview

Table 86. AstraZeneca Human Immunodeficiency Virus Type-1 Product

Table 87. AstraZeneca Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 88. AstraZeneca Recent Development

Table 89. Novartis Company Details

Table 90. Novartis Business Overview

Table 91. Novartis Human Immunodeficiency Virus Type-1 Product

Table 92. Novartis Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 93. Novartis Recent Development

Table 94. Bayer Company Details

Table 95. Bayer Business Overview

Table 96. Bayer Human Immunodeficiency Virus Type-1 Product

Table 97. Bayer Revenue in Human Immunodeficiency Virus Type-1 Business (US$ Million), 2021–2026

Table 98. Bayer Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Human Immunodeficiency Virus Type-1 Picture

Figure 2. Global Human Immunodeficiency Virus Type-1 Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Human Immunodeficiency Virus Type-1 Market Share by Type: 2025 vs 2032

Figure 4. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features

Figure 5. Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Features

Figure 6. Protease Inhibitors (PIs) Features

Figure 7. Integrase Inhibitor Features

Figure 8. Others Features

Figure 9. Global Human Immunodeficiency Virus Type-1 Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Human Immunodeficiency Virus Type-1 Market Share by Application: 2025 vs 2032

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Human Immunodeficiency Virus Type-1 Report Years Considered

Figure 14. Global Human Immunodeficiency Virus Type-1 Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Human Immunodeficiency Virus Type-1 Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Human Immunodeficiency Virus Type-1 Market Share by Region: 2025 vs 2032

Figure 17. Global Human Immunodeficiency Virus Type-1 Market Share by Players in 2025

Figure 18. Global Human Immunodeficiency Virus Type-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus Type-1 Revenue in 2025

Figure 20. North America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)

Figure 22. United States Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)

Figure 26. Germany Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Human Immunodeficiency Virus Type-1 Market Share by Region (2021–2032)

Figure 34. China Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)

Figure 42. Mexico Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Human Immunodeficiency Virus Type-1 Market Share by Country (2021–2032)

Figure 46. Israel Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Human Immunodeficiency Virus Type-1 Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Roche Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 50. Bristol Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 51. Merck & Co. Inc. Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 52. GSK Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 53. Pfizer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 54. Viatris Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 55. Sanofi Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 56. AstraZeneca Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 57. Novartis Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 58. Bayer Revenue Growth Rate in Human Immunodeficiency Virus Type-1 Business (2021–2026)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HIV Vaccine Market Research Report 2025

Global HIV Clinical Trials Market Research Report 2025

Global HIV and AIDS Vaccine Market Research Report 2024

Global HIV and AIDS Clinical Trials Market Research Report 2025

Global Long acting Anti HIV Drug Market Research Report 2024

Global HIV Prevention Drug Market Research Report 2024

Global Human Immunodeficiency Virus Rapid Test Kit Market Research Report 2024

Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Highly Active Antiretroviral Therapy HAART Market Research Report 2024

Pediatric HIV Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Immunodeficiency Virus HIV Rapid Test Kits Market Insights Forecast to 2030

Global Artificial Intelligence AI in HIV and AIDS Market Research Report 2024

Global Anti AIDs Drug Market Insights Forecast to 2030

Global Interleukin 1 Alpha Market Research Report 2024

Global Human Immunodeficiency Virus Testing Market Research Report 2024

Global Human Immunoglobulin Market Research Report 2024

Global Patient Hygiene Aids Market Research Report 2024

HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prophylactic HIV Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions